As­traZeneca throws a mon­key wrench in new GSK CEO’s first hir­ing de­ci­sion, su­ing Luke Miels

Back at the be­gin­ning of this year, one of Em­ma Walm­s­ley’s first moves as in­com­ing CEO of Glax­o­SmithK­line was to poach Luke Miels from As­traZeneca to head up the glob­al phar­ma­ceu­ti­cals busi­ness. Miels’ ex­pe­ri­ence in phar­ma and his ear­li­er role man­ag­ing the port­fo­lio and strat­e­gy at As­traZeneca, she said, gave him in­sights on R&D and the in­dus­try that would make him unique­ly suit­ed to the job.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.